MMP2 and ovarian carcinoma: Most of the tested metalloproteinases upregulated mRNA expression in both FIGO I/II and FIGO III/IV stages of ovarian cancer (MMP1, MMP13, MMP2, MMP9, MMP10, MMP7, MMP12 and MMP14) indicating profound modifications of the extracellular matrix.